Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2022 Annual General Meeting

NEXT STORY
World Immunoassay Market Strategies and Trends Report 2022 to 2026: Immunoassay vs. PCR vs. Sequencing – A See-Saw Battle
PREV STORY
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt

author_avatar
NASDAQ Market News

U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide [rDNA origin]) for Children with Short Bowel Syndrome

Intended for U.S. Audience U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application ...

author_avatar
NASDAQ Market News

SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference

author_avatar
NASDAQ Market News